Novartis share rose on getting right to sell the MS pill

After it won a U.S regulatory advisory panel’s support for launching the first pill for the treatment of multiple sclerosis, share of Novartis AG rose 3.1 percent in Zurich trading. Advisors to the Food and Drug Adminstration have voted 21-3 in favor of the pill and it gave boost to the share prices of the